NYSE: BHC $8 Billion Mid-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 70%. 1 Year Return 11%. 2021 YTD Return 23%. Since Earnings 52%.
The 52 Week Low is $11.15 set on Wed, Mar 18, 2020.
The 52 Week High is $30.39 set on Fri, Jan 17, 2020.
The All-Time High is $263.79 set on Wed, Aug 5, 2015.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Bausch Health Companies Inc. Common Stock trades on the NYSE. BHC's market cap is 9.4 Billion.
Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in four segments: Bausch+Lomb and international (55% of revenue), Salix pharmaceuticals (25%), ortho dermatology (6%), and diversified products (14%), and approximately 13% of revenue is attributable to non-U.S. markets. Bausch is the market leader in consumer visioncare in India and China, and the fourth- largest visioncare company by sales in the United States.
For Starters
Track your portfolio and more.
